519 related articles for article (PubMed ID: 31344486)
1. Multi-modal latent factor exploration of atrophy, cognitive and tau heterogeneity in Alzheimer's disease.
Sun N; Mormino EC; Chen J; Sabuncu MR; Yeo BTT;
Neuroimage; 2019 Nov; 201():116043. PubMed ID: 31344486
[TBL] [Abstract][Full Text] [Related]
2. Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer's disease.
Zhang X; Mormino EC; Sun N; Sperling RA; Sabuncu MR; Yeo BT;
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6535-E6544. PubMed ID: 27702899
[TBL] [Abstract][Full Text] [Related]
3. Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease.
Phillips JS; Das SR; McMillan CT; Irwin DJ; Roll EE; Da Re F; Nasrallah IM; Wolk DA; Grossman M
Hum Brain Mapp; 2018 Feb; 39(2):691-708. PubMed ID: 29105977
[TBL] [Abstract][Full Text] [Related]
4. Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline.
Ten Kate M; Dicks E; Visser PJ; van der Flier WM; Teunissen CE; Barkhof F; Scheltens P; Tijms BM;
Brain; 2018 Dec; 141(12):3443-3456. PubMed ID: 30351346
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
6. Medial Temporal Lobe Networks in Alzheimer's Disease: Structural and Molecular Vulnerabilities.
de Flores R; Das SR; Xie L; Wisse LEM; Lyu X; Shah P; Yushkevich PA; Wolk DA
J Neurosci; 2022 Mar; 42(10):2131-2141. PubMed ID: 35086906
[TBL] [Abstract][Full Text] [Related]
7. Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.
Schöll M; Ossenkoppele R; Strandberg O; Palmqvist S; ; Jögi J; Ohlsson T; Smith R; Hansson O
Brain; 2017 Sep; 140(9):2286-2294. PubMed ID: 29050382
[TBL] [Abstract][Full Text] [Related]
8. Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease.
Nho K; Risacher SL; Crane PK; DeCarli C; Glymour MM; Habeck C; Kim S; Lee GJ; Mormino E; Mukherjee S; Shen L; West JD; Saykin AJ;
Brain Imaging Behav; 2012 Dec; 6(4):551-67. PubMed ID: 23070747
[TBL] [Abstract][Full Text] [Related]
9. Regional atrophy is associated with impairment in distinct cognitive domains in Alzheimer's disease.
Smits LL; Tijms BM; Benedictus MR; Koedam EL; Koene T; Reuling IE; Barkhof F; Scheltens P; Pijnenburg YA; Wattjes MP; van der Flier WM
Alzheimers Dement; 2014 Oct; 10(5 Suppl):S299-305. PubMed ID: 24210526
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers.
Dong A; Toledo JB; Honnorat N; Doshi J; Varol E; Sotiras A; Wolk D; Trojanowski JQ; Davatzikos C;
Brain; 2017 Mar; 140(3):735-747. PubMed ID: 28003242
[TBL] [Abstract][Full Text] [Related]
11. Multi-pathological contributions toward atrophy patterns in the Alzheimer's disease continuum.
Mohanty R; Ferreira D; Westman E
Front Neurosci; 2024; 18():1355695. PubMed ID: 38655107
[TBL] [Abstract][Full Text] [Related]
12. Temporal tau asymmetry spectrum influences divergent behavior and language patterns in Alzheimer's disease.
Younes K; Smith V; Johns E; Carlson ML; Winer J; He Z; Henderson VW; Greicius MD; Young CB; Mormino EC;
Brain Behav Immun; 2024 Jul; 119():807-817. PubMed ID: 38710339
[TBL] [Abstract][Full Text] [Related]
13. The identification of cognitive subtypes in Alzheimer's disease dementia using latent class analysis.
Scheltens NM; Galindo-Garre F; Pijnenburg YA; van der Vlies AE; Smits LL; Koene T; Teunissen CE; Barkhof F; Wattjes MP; Scheltens P; van der Flier WM
J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):235-43. PubMed ID: 25783437
[TBL] [Abstract][Full Text] [Related]
14. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.
Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ
J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.
Davatzikos C; Xu F; An Y; Fan Y; Resnick SM
Brain; 2009 Aug; 132(Pt 8):2026-35. PubMed ID: 19416949
[TBL] [Abstract][Full Text] [Related]
16. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
17. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
[TBL] [Abstract][Full Text] [Related]
18. Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study.
Cho H; Choi JY; Lee HS; Lee JH; Ryu YH; Lee MS; Jack CR; Lyoo CH
J Nucl Med; 2019 Nov; 60(11):1611-1621. PubMed ID: 30926651
[TBL] [Abstract][Full Text] [Related]
19. Tau and atrophy: domain-specific relationships with cognition.
Digma LA; Madsen JR; Reas ET; Dale AM; Brewer JB; Banks SJ;
Alzheimers Res Ther; 2019 Jul; 11(1):65. PubMed ID: 31351484
[TBL] [Abstract][Full Text] [Related]
20. Biological heterogeneity in ADNI amnestic mild cognitive impairment.
Nettiksimmons J; DeCarli C; Landau S; Beckett L;
Alzheimers Dement; 2014 Sep; 10(5):511-521.e1. PubMed ID: 24418061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
